Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
Compare Balance Sheet Results of Biogen Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
65.26
5.80
59.46
1,025.17%
Share Warrants & Outstandings
Total Reserve
-9.03
12.76
-21.79
-170.77%
Shareholder's Funds
91.93
18.56
73.37
395.31%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0
0
0.00
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00%
Other Long Term Liabilities
0.09
0.00
0.09
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.00
0.00
0.00%
Current Liabilities
Trade Payables
0.00
0.01
-0.01
-100.00%
Other Current Liabilities
0.00
0.00
0.00
0.00%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.18
0.04
0.14
350.00%
Total Liabilities
92.02
18.61
73.41
394.47%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
0.01
-0.01
-100.00%
Less: Accumulated Depreciation
0.00
0.00
0.00
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.01
-0.01
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0
0
0.00
0.00%
Long Term Loans & Advances
65.50
0.00
65.50
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.57
0.01
0.56
5,600.00%
Current Assets Loans & Advances
Current Investments
23.84
0.00
23.84
0.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
0.00
0.00
0.00%
Cash and Bank
2.02
0.11
1.91
1,736.36%
Other Current Assets
0
0
0.00
0.00%
Short Term Loans and Advances
0.00
0.00
0.00
0.00%
Total Current Assets
25.86
0.11
25.75
23,409.09%
Net Current Assets (Including Current Investments)
25.68
0.07
25.61
36,585.71%
Total Current Assets Excluding Current Investments
2.02
0.11
1.91
1,736.36%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
92.02
18.61
73.41
394.47%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
0.86
31.99
-31.13
-97.31%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
